IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

283 hedge funds and large institutions have $2.2B invested in Iovance Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 108 increasing their positions, 83 reducing their positions, and 47 closing their positions.

Holders
283
Holders Change
-11
Holders Change %
-3.74%
% of All Funds
4.09%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.13%
New
38
Increased
108
Reduced
83
Closed
47
Calls
$44.1M
Puts
$24.7M
Net Calls
+$19.4M
Net Calls Change
+$12.7M

Top Buyers

1
HRCM
1
Hood River Capital Management
Florida
$76.5M
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$55M
3
Macquarie Group
3
Macquarie Group
Australia
$30M
4
Goldman Sachs
4
Goldman Sachs
New York
$41.2M
5
Principal Financial Group
5
Principal Financial Group
Iowa
$37.9M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$39.8M
2
Voloridge Investment Management
2
Voloridge Investment Management
Florida
$1.03M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$17.8M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
SPPAM
5
Summit Partners Public Asset Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$256M 27,313,967 +1,363,323 +5%
PA
2
Perceptive Advisors
New York
$250M 26,617,709 +684,567 +3%
MFM
3
MHR Fund Management
New York
$225M 23,997,103 – –
BlackRock
4
BlackRock
New York
$202M 21,483,668 +258,549 +1%
State Street
5
State Street
Massachusetts
$124M 13,201,978 +576,801 +5%
SCM
6
Soleus Capital Management
Connecticut
$80.1M 8,528,500 +980,500 +13%
HRCM
7
Hood River Capital Management
Florida
$76.5M 8,144,637 +5,412,210 +198%
T. Rowe Price Investment Management
8
T. Rowe Price Investment Management
Maryland
$55M 5,861,279 +3,810,779 +186%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$53.1M 5,648,995 -137,537 -2%
Artisan Partners
10
Artisan Partners
Wisconsin
$45.1M 4,803,825 -307,584 -6%
LFCM
11
Long Focus Capital Management
Puerto Rico
$42.6M 4,532,000 +400,000 +10%
Balyasny Asset Management
12
Balyasny Asset Management
Illinois
$42M 4,472,576 -67,984 -1%
Goldman Sachs
13
Goldman Sachs
New York
$41.2M 4,390,032 +1,768,248 +67%
ACA
14
Avoro Capital Advisors
New York
$39.8M 4,240,000 -7,460,000 -64%
Principal Financial Group
15
Principal Financial Group
Iowa
$37.9M 4,033,184 +1,496,941 +59%
Macquarie Group
16
Macquarie Group
Australia
$30M 3,190,036 +3,190,036 New
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$29.1M 3,102,912 -379,490 -11%
PAI
18
Palo Alto Investors
California
$28.6M 3,041,685 +925,282 +44%
Bank of America
19
Bank of America
North Carolina
$23M 2,450,838 +283,613 +13%
MB
20
MPM BioImpact
Massachusetts
$22.6M 2,406,714 +40,000 +2%
Northern Trust
21
Northern Trust
Illinois
$21.1M 2,248,576 +81,618 +4%
Morgan Stanley
22
Morgan Stanley
New York
$20.2M 2,148,574 -674,289 -24%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$19.4M 2,069,592 -195,963 -9%
UBS AM
24
UBS AM
Illinois
$18.3M 1,946,842 -47,658 -2%
Charles Schwab
25
Charles Schwab
California
$18M 1,913,144 -71,801 -4%
1
2 3 4 5